Trials / Withdrawn
WithdrawnNCT01060319
A Comprehensive Study to Isolate Tumor-initiating Cells From Human Epithelial Malignancies
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
We hypothesize that all human malignancies harbour a subpopulation of tumor initiating cells/cancer stem cells (CSCs) that drives tumor development and potentially recurrence or metastasis of the disease. The primary aim of this study is to develop strategies for prospective isolation/enrichment of CSCs from human tumors of different tissue origins. In addition, we will characterize the signaling pathways and/or tumor specific antigens that are specific for CSCs, in order to specifically target these CSCs as the endpoint of this study.
Conditions
- Bladder Cancer
- Skin Cancers
- Bladder (Urothelial, Transitional Cell) Cancer
- Bladder (Urothelial, Transitional Cell) Cancer Resectable (Pre-Cystectomy)
Timeline
- Start date
- 2013-12-01
- Primary completion
- 2014-12-01
- Completion
- 2014-12-01
- First posted
- 2010-02-02
- Last updated
- 2019-04-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01060319. Inclusion in this directory is not an endorsement.